International Impact of COVID-19 on the Diagnosis of Heart Disease

Andrew J. Einstein(NewYork–Presbyterian Hospital), Leslee J. Shaw(NewYork–Presbyterian Hospital), Cole B. Hirschfeld(NewYork–Presbyterian Hospital), Michelle A. Williams(University of Edinburgh), Todd C. Villines(University of Virginia), Nathan Better(The Royal Melbourne Hospital), João V. Vítola, Rodrigo Cerci, Sharmila Dorbala(Brigham and Women's Hospital), Paolo Raggi(University of Alberta), Andrew D. Choi(George Washington University), Bin Lü, В. Е. Синицын(Lomonosov Moscow State University), В. Б. Сергиенко(National Medical Research Center of Cardiology), Takashi Kudo(Nagasaki University), Bjarne Linde Nørgaard(Aarhus University Hospital), Pál Maurovich‐Horvat(Semmelweis University), Roxana Campisi(Diagnostico Maipú), Elisa Milan(Ca' Foncello Hospital), Lizette Louw(Wits University Donald Gordon Medical Centre), Adel H. Allam(Al-Azhar University), Mona Bhatia(Fortis Escorts Heart Institute), Eli Malkovskiy(NewYork–Presbyterian Hospital), Benjamin Goebel(NewYork–Presbyterian Hospital), Yosef Cohen(NewYork–Presbyterian Hospital), Michael Randazzo(NewYork–Presbyterian Hospital), Jagat Narula(NewYork–Presbyterian Hospital), Thomas N.B. Pascual(NewYork–Presbyterian Hospital), Yaroslav Pynda(International Atomic Energy Agency), Maurizio Dondi(International Atomic Energy Agency), Diana Páez(International Atomic Energy Agency)
Journal of the American College of Cardiology
January 1, 2021
Cited by 192Open Access
Full Text

Abstract

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. OBJECTIVES: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. METHODS: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. RESULTS: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower-middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. CONCLUSIONS: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19-related changes in care delivery is warranted.


Related Papers

No related papers found

Powered by citation graph analysis